M. Arockia Babu

678 total citations
62 papers, 404 citations indexed

About

M. Arockia Babu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, M. Arockia Babu has authored 62 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 16 papers in Organic Chemistry and 10 papers in Pharmacology. Recurrent topics in M. Arockia Babu's work include Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (9 papers) and Telomeres, Telomerase, and Senescence (5 papers). M. Arockia Babu is often cited by papers focused on Synthesis and biological activity (13 papers), Computational Drug Discovery Methods (9 papers) and Telomeres, Telomerase, and Senescence (5 papers). M. Arockia Babu collaborates with scholars based in India, Saudi Arabia and United Arab Emirates. M. Arockia Babu's co-authors include Ankit Gupta, Jitender Madan, Ramesh Chandra, Monika Chaudhary, Neeraj Kumar, Ashish Baldi, Philip Prathipati, Anil K. Saxena, Pradeep Kumar and Rakesh K. Sindhu and has published in prestigious journals such as Frontiers in Immunology, Drug Discovery Today and Clinica Chimica Acta.

In The Last Decade

M. Arockia Babu

48 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Arockia Babu India 13 135 129 72 60 33 62 404
Subham Das India 14 165 1.2× 170 1.3× 83 1.2× 59 1.0× 49 1.5× 42 563
Farhad Eisvand Iran 13 190 1.4× 211 1.6× 51 0.7× 76 1.3× 15 0.5× 26 602
Maria Mernea Romania 11 138 1.0× 59 0.5× 58 0.8× 34 0.6× 33 1.0× 47 359
Fang Xie China 10 236 1.7× 167 1.3× 42 0.6× 63 1.1× 21 0.6× 37 501
Pritha Bose India 9 149 1.1× 96 0.7× 53 0.7× 34 0.6× 35 1.1× 16 352
Marc Since France 14 180 1.3× 190 1.5× 123 1.7× 158 2.6× 25 0.8× 32 529
Ichiro Hijikuro Japan 11 141 1.0× 150 1.2× 52 0.7× 92 1.5× 18 0.5× 24 401
Samiye Yabanoğlu‐Çiftçi Türkiye 13 94 0.7× 88 0.7× 33 0.5× 74 1.2× 43 1.3× 25 393
Muthusamy Ramesh India 13 201 1.5× 104 0.8× 67 0.9× 40 0.7× 17 0.5× 29 474
Manal A. Nael Egypt 10 167 1.2× 117 0.9× 29 0.4× 44 0.7× 70 2.1× 20 406

Countries citing papers authored by M. Arockia Babu

Since Specialization
Citations

This map shows the geographic impact of M. Arockia Babu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Arockia Babu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Arockia Babu more than expected).

Fields of papers citing papers by M. Arockia Babu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Arockia Babu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Arockia Babu. The network helps show where M. Arockia Babu may publish in the future.

Co-authorship network of co-authors of M. Arockia Babu

This figure shows the co-authorship network connecting the top 25 collaborators of M. Arockia Babu. A scholar is included among the top collaborators of M. Arockia Babu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Arockia Babu. M. Arockia Babu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goyal, Kavita, Muhammad Afzal, M. Arockia Babu, et al.. (2025). Icariin as a therapeutic agent in breast cancer: modulating apoptosis and suppressing proliferation. Journal of Complementary and Integrative Medicine. 22(3). 417–426.
2.
Puri, S.K., M. Arockia Babu, Sarvesh Kumar Pandey, et al.. (2025). A Minireview on the Morpholine-Ring-Containing U.S. FDA Approved Drugs: A Medicinal-Chemistry-Based Analysis from 2013 to 2023. Synlett. 36(16). 2527–2536. 1 indexed citations
3.
Alaseem, Ali M., M. Arockia Babu, Prawez Alam, et al.. (2025). Employing a drug repurposing strategy to identify B-cell lymphoma-2 (BCL-2) inhibitors with anticancer potential: An in silico and in vitro based study. Bioorganic & Medicinal Chemistry. 130. 118364–118364.
4.
5.
Babu, M. Arockia, Kavita Goyal, Soumya V. Menon, et al.. (2025). Targeting NLRP3 inflammasome with curcumin: mechanisms and therapeutic promise in chronic inflammation. Inflammopharmacology. 33(10). 5667–5687.
6.
Samuel, Vijaya Paul, Muhammad Afzal, M. Arockia Babu, et al.. (2025). Targeting gasdermin D–mediated pyroptosis: a precision anti-inflammatory strategy for acute and chronic lung diseases. Inflammopharmacology. 34(1). 181–203.
7.
Bansal, Nisha, M. Arockia Babu, Ganesh Bushi, et al.. (2025). Pyrazole in drug development: a medicinal-chemistry based analysis of USFDA-approved drugs in last decade. Molecular Diversity. 30(1). 197–220. 2 indexed citations
8.
Altamimi, Abdulmalik Saleh Alfawaz, et al.. (2025). The interplay of senescence and MMPs in myocardial infarction: implications for cardiac aging and therapeutics. Biogerontology. 26(1). 46–46. 1 indexed citations
9.
Almohmadi, Najlaa H., Rakesh K. Sindhu, M. Arockia Babu, et al.. (2025). Nanocarrier-based Drug Delivery Systems: A Way to Effective Diabetes Management. BioNanoScience. 15(2).
10.
Saharan, Renu, Sarvesh Paliwal, Abhishek Tiwari, et al.. (2024). Beyond traditional hydrogels: The emergence of graphene oxide-based hydrogels in drug delivery. Journal of Drug Delivery Science and Technology. 94. 105506–105506. 19 indexed citations
11.
Singh, Kuldeep, Jeetendra Kumar Gupta, Kamal Shah, et al.. (2024). Harnessing the Pyrazine Moiety for Potent Anti-inflammatory Activity: AComprehensive Review. Current Organic Chemistry. 28(3). 176–184.
12.
Chauhan, Payal, Sumel Ashique, M. Arockia Babu, et al.. (2024). Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease. Biomedicine & Pharmacotherapy. 174. 116376–116376. 20 indexed citations
13.
Babu, M. Arockia, Ehssan Moglad, Supriya Gupta, et al.. (2024). Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathology - Research and Practice. 266. 155785–155785. 13 indexed citations
14.
Sharma, Teenu, et al.. (2024). Lipid-based Nanocarriers for mRNA Delivery: Vital Considerations andApplications. Nanoscience & Nanotechnology-Asia. 14(1). 1 indexed citations
15.
Gürer, Eda Sönmez, et al.. (2023). Asian Veterinary Medicines: From the Past to the Future. Journal of Research in Pharmacy. 27(4)(27(4)). 1313–1328.
16.
Babu, M. Arockia, et al.. (2005). Recent Therapeutic Approaches For Management Of Alzheimer's Disease. Indian Journal of Pharmaceutical Sciences. 67(1). 1–10. 2 indexed citations
17.
Babu, M. Arockia, et al.. (2004). 3D-QSAR CoMFA CoMSIA Studies On Indomethacin Derivatives As Selective Cyclooxygenase-2 Inhibitors. Indian Journal of Pharmaceutical Sciences. 66(5). 613–620. 2 indexed citations
18.
Gupta, Ankit, et al.. (2004). VALSTAT: Validation program for quantitative structure activity relationship studies. Indian Journal of Pharmaceutical Sciences. 66(4). 396–402. 43 indexed citations
19.
Kumar, P. Senthil, et al.. (2003). 3D-QSAR Analysis Of Substituted 1,3,4-Triaryl-3-Pyrrolin-2-Ones As Selective Cyclooxygenase-2-Inhibitors. Indian Journal of Pharmaceutical Sciences. 65(3). 244–249. 2 indexed citations
20.
Babu, M. Arockia, et al.. (2003). A 3D-QSAR Study Of Some Substituted Napthols As 5-Lipoxygenase Inhibitors. Indian Journal of Pharmaceutical Sciences. 65(4). 351–357. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Subham Das Breakdown of academic impact, for papers by Farhad Eisvand Breakdown of academic impact, for papers by Maria Mernea Breakdown of academic impact, for papers by Fang Xie Breakdown of academic impact, for papers by Pritha Bose Breakdown of academic impact, for papers by Marc Since Breakdown of academic impact, for papers by Ichiro Hijikuro Breakdown of academic impact, for papers by Samiye Yabanoğlu‐Çiftçi Breakdown of academic impact, for papers by Muthusamy Ramesh Breakdown of academic impact, for papers by Manal A. Nael
Rankless by CCL
2026